Claims
- 1. A method of making a transgenic plant with increased meristematic activity comprising introducing into one or more cells of a plant exogenous nucleic acid which alters expression of vacuolar pyrophosphatase in the plant so to increase vacuolar pyrophosphatase activity, to yield transformed cells in the plant, thereby producing a transgenic plant which has increased meristematic activity.
- 2. The method of claim 1 further comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant which has increased meristematic activity, thereby producing a transgenic plant with improved meristematic activity.
- 3. The method of claim 1 wherein the exogenous nucleic acid encodes AVP1 or homologue thereof.
- 4. The method of claim 3 wherein the AVP1 or AVP1 homologue is present in a construct designed to overexpress AVP1.
- 5. The method of claim 4 wherein the construct comprises the AVP1 gene or AVP1 homologue is operably linked to a chimeric promoter designed to overexpress AVP1 or homologue thereof.
- 6. The method of claim 5 wherein the AVP1 gene or homologue thereof is operably linked to a chimeric promoter selected from the group consisting of:
tissue specfic promoters, constitutive promoters, inducible promoters and combinations thereof.
- 7. The method of claim 5 wherein the AVP1 gene or AVP1 homologue is operably linked to a double tandem enhancer of a 35S promoter.
- 8. The method of claim 3 wherein the AVP1, or homologue thereof, is derived from a wild type plant.
- 9. The method of claim 3 wherein the AVP1, or homologue thereof, is derived from a transgenic plant.
- 10. The method of claim 3 wherein the AVP1, or homologue thereof, is derived from a mutant plant.
- 11. The method of claim 3 wherein the AVP1, or homologue thereof, is synthetically derived.
- 12. The method of claim 3 wherein the AVP1, or homologue thereof, is naturally and synthetically derived.
- 13. A transgenic plant produced by the method of claim 1.
- 14. A method of making a transgenic plant with increased meristematic competence comprising introducing into one or more cells of a plant exogenous nucleic acid which alters expression of vacuolar pyrophosphatase so as to increase vacuolar pyrophosphatase activity in the plant to yield transformed cells in the plant, thereby producing a transgenic plant which has increased meristematic competence.
- 15. The method of claim 14 further comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant which has increased meristematic activity, thereby producing a transgenic plant with improved meristematic activity.
- 16. The method of claim 14 wherein the exogenous nucleic acid encodes AVP1 or homologue thereof.
- 17. The method of claim 16 wherein the AVP1 or AVP1 homologue is present in a construct designed to overexpress AVP1.
- 18. The method of claim 17 wherein the construct comprises the AVP1 gene or AVP1 homologue is operably linked to a chimeric promoter designed to overexpress AVP1 or homologue thereof.
- 19. The method of claim 18 wherein the AVP1 gene or homologue thereof is operably linked to a chimeric promoter selected from the group consisting of:
tissue specfic promoters, constitutive promoters, inducible promoters and combinations thereof.
- 20. The method of claim 18 wherein the AVP1 gene or AVP1 homologue is operably linked to a double tandem enhancer of a 35 S promoter.
- 21. The method of claim 16 wherein the AVP1, or homologue thereof, is derived from a wild type plant.
- 22. The method of claim 16 wherein the AVP 1, or homologue thereof, is derived from a transgenic plant.
- 23. The method of claim 16 wherein the AVP 1, or homologue thereof, is derived from a mutant plant.
- 24. The method of claim 16 wherein the AVP 1, or homologue thereof, is synthetically derived.
- 25. The method of claim 16 wherein the AVP 1, or homologue thereof, is naturally and synthetically derived.
- 26. A method of making a transgenic plant with increased biomass comprising introducing into one or more cells of a plant a nucleic acid construct which alters. expression of vacuolar pyrophosphatase so as to increase vacuolar pyrophosphatase activity in the cell to yield transformed cells thereby producing a transgenic plant with increased biomass.
- 27. The method of claim 26 further comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant with increased biomass.
- 28. A transgenic plant produced by the method of claim 26
- 29. A method of making a transgenic plant with an increased biomass over its corresponding wild type plant, wherein the increased biomass relates to an increase in the biomass of a plant part selected from the group consisting of: leaves, stems, roots, seeds, flowers, and fruits, said method comprising introducing into one or more cells of a plant, an exogenous nucleic acid which alters expression of vacuolar pyrophosphatase such so as to enhance the activity of the vacuolar pyrophosphatase in the plant to yield transformed cells, thereby producing a transgenic plant with an increased biomass.
- 30. The method of claim 29 further comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant which is larger than its corresponding wild type plant, thereby producing a transgenic plant with an increased biomass.
- 31. The method of claim 29 wherein the exogenous nucleic acid encodes AVP1, or homologue thereof.
- 32. The method of claim 31 wherein the AVP1, or homologue thereof, is present in a construct designed to overexpress AVP 1, or homologue thereof.
- 33. The method of claim 32 wherein the construct comprises the AVP1 gene, or homologue thereof, operably linked to a chimeric promoter designed to overexpress AVP1.
- 34. The method of claim 33 wherein the AVP1 gene or homologue thereof is operably linked to a chimeric promoter selected from the group consisting of: tissue specfic promoters, constitutive promoters, inducible promoters and combinations thereof
- 35. The method of claim 32 wherein the AVP1 gene, or homologue thereof, is operably linked to a double tandem enhancer of a 35S promoter.
- 36. The method of claim 31 wherein the AVP1, or homologue thereof, is derived from a wild type plant.
- 37. The method of claim 31 wherein the AVP1, or homologue thereof, is derived from a transgenic plant.
- 38. The method of claim 31 wherein the AVP1, or homologue thereof, is derived from a mutant plant.
- 39. The method of claim 29 wherein the transgenic plant is grown in soil.
- 40. The method of claim 29 wherein the transgenic plant is grown hydroponically.
- 41. The method of claim 29 wherein a cell from the transgenic plant is grown in culture.
- 42. A transgenic plant produced by the method of claim 29.
- 43. A method of producing a transgenic plant with a stem structure thicker than wild type comprising introducing into one or more cells of a plant exogenous nucleic acid which alters expression of vacuolar pyrophosphatase so as to increase vacuolar pyrophosphatase activity in the plant to yield transformed cells, thereby producing a transgenic plant with a thickened stem structure.
- 44. The method of claim 43 wherein the stem structure is selected from group consisting of: wood, bark and cambium.
- 45. The method of claim 43 further comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant with a thickened stem structure, thereby producing a transgenic plant with thickened stem structure.
- 46. A method of making a transgenic plant having increased root structure compared to its corresponding wild type plant comprising introducing into one or more cells of a exogenous nucleic acid which alters expression of vacuolar pyrophosphatase so as to increase vacuolar pyrophosphatase activity in the plant to yield transformed cells, thereby producing a transgenic plant having increased root structure.
- 47. The method of claim 46 wherein the exogenous nucleic acid encodes AVP1, or homologue thereof.
- 48. A transgenic plant produced by the method of claim 46.
- 49. A method of making a transgenic plant having increased shoot regeneration capacity as compared to its corresponding wild type plant comprising introducing into one or more cells of a plant nucleic acid which alters expression of vacuolar pyrophosphatase so as to increase vacuolar pyrophosphatase activity in the plant to yield transformed cells, thereby producing a transgenic plant having increased shoot regeneration capacity.
- 50. The method of claim 49 fuirther comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant which has increased shoot regeneration capacity, thereby producing a transgenic plant with improved shoot regeneration capacity.
- 51. The method of claim 49 wherein the exogenous nucleic acid encodes AVP1, or homologue thereof.
- 52. The method of claim 51 wherein the AVP1, or AVP1 homologue, is present in a construct designed to overexpress AVP1.
- 53. The method of claim 52 wherein the construct that comprises the AVP1 gene or AVP1 homologue is operably linked to a chimeric promoter designed to overexpress AVP1 or homologue thereof.
- 54. The method of claim 53 wherein the AVP1 gene or homologue thereof is operably linked to a chimeric promoter selected from the group consisting of:
tissue specfic promoters, constitutive promoters, inducible promoters and combinations thereof.
- 55. The method of claim 53 wherein the AVP1 gene or AVP1 homologue is operably linked to a double tandem enhancer of a 35S promoter.
- 56. The method of claim 52 wherein the AVP1, or homologue thereof, is derived from a wild type plant.
- 57. The method of claim 52 wherein the AVP1, or homologue thereof, is derived from a transgenic plant.
- 58. The method of claim 52 wherein the AVP1, or homologue thereof, is derived from a mutant plant.
- 59. The method of claim 52 wherein the AVP1, or homologue thereof, is synthetically derived.
- 60. The method of claim 52 wherein the AVP1, or homologue thereof, is naturally and synthetically derived.
- 61. A transgenic plant produced by the method of claim 49.
- 62. A method of making a transgenic plant having increased root regeneration capacity as compared to its corresponding wild type plant comprising introducing into one or more cells of a plant nucleic acid which alters expression of vacuolar pyrophosphatase so as to increase vacuolar pyrophosphatase activity in the plant to yield transformed cells, thereby producing a transgenic plant having increased root structure.
- 63. The method of claim 62 flirther comprising regenerating plants from the transformed cells to yield transgenic plants and selecting a transgenic plant which has increased root regeneration capacity, thereby producing a transgenic plant with improved root regeneration capacity.
- 64. The method of claim 62 wherein the exogenous nucleic acid encodes AVP1, or homologue thereof.
- 65. The method of claim 64 wherein the AVP1, or AVP1 homologue, is present in a construct designed to overexpress AVP1.
- 66. The method of claim 65 wherein the construct that comprises the AVP1 gene or AVP1 homologue is operably linked to a chimeric promoter designed to overexpress AVP1 or homologue thereof.
- 67. The method of claim 66 wherein the AVP1 gene or homologue thereof is operably linked to a chimeric promoter selected from the group consisting of:
tissue specfic promoters, constitutive promoters, inducible promoters and combinations thereof.
- 68. The method of claim 64 wherein the AVP1 gene or AVP1 homologue is operably linked to a double tandem enhancer of a 35S promoter.
- 69. The method of claim 64 wherein the AVP1, or homologue thereof, is derived from a wild type plant.
- 70. The method of claim 64 wherein the AVP1, or homologue thereof, is derived from a transgenic plant.
- 71. The method of claim 64 wherein the AVP1, or homologue thereof, is derived from a mutant plant.
- 72. The method of claim 64 wherein the AVP1, or homologue thereof, is synthetically derived.
- 73. The method of claim 64 wherein the AVP1, or homologue thereof, is naturally and synthetically derived.
- 74. A transgenic plant produced by the method of claim 62.
RELATED APPLICATION(S)
[0001] To the extent possible under the law of the respective countries designated with respect to this PCT application, this application claims the benefit of U.S. Provisional Application No. 60/164,808, entitled “Proton Transporters and Uses in Plants” by Roberto Gaxiola, filed Nov. 10, 1999, U.S. patent application Ser. No. 09/644,039 entitled “Proton Transporters and Uses in Plants” by Roberto Gaxiola, filed Aug. 22, 2000, U.S. Provisional Application No. 60/226223, entitled “Drought/Freeze Resistant Transgenic Plants” by Roberto Gaxiola, filed Aug. 18, 2000, and PCT Application No. PCT/US00/30955, entitled “Stress-Resistant Oversized Transgenic Plants Capable of Growing in Salinized Soil”, filed Nov. 10, 2000, and the entire teachings of each application, to the extent possible under the appropriate foreign law, are incorporated herein by reference.
GOVERNMENT SUPPORT
[0002] The invention described herein was supported, in whole or in part, by grants GM52414, DK54214, DK43495, DK51509, DK34854 and GM35010 from the National Institutes of Health and by grant MCB9317175 from the National Science Foundation. The Government has certain rights in the invention.
PCT Information
Filing Document |
Filing Date |
Country |
Kind |
PCT/US01/09548 |
3/24/2001 |
WO |
|